Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

31
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial Oedema in Heart Failure with Preserved Ejection Fraction: Preliminary Findings from the NETDiamond Cohort.

European journal of heart failure·2026
Same author

Myocardial expression of <i>ADGRL4</i> and <i>AQP7</i> is related to regression of left ventricular hypertrophy after aortic valve replacement in a sex-dependent manner.

American journal of physiology. Heart and circulatory physiology·2026
Same author

One Health Insights into Pulmonary Hypertension: Bridging Human and Canine Medicine.

Veterinary sciences·2026
Same author

Artificial Intelligence in Pulmonary Endoscopy: Current Evidence, Limitations, and Future Directions.

Journal of imaging·2026
Same author

Correction to: Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection Fraction.

Circulation. Heart failure·2026
Same author

Oral-heart axis from pregnancy and postpartum: maternal oral microbiota relates with cardiac reverse remodeling.

Journal of oral microbiology·2026

Related Experiment Video

Updated: Sep 26, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K

Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering.

Rúben Almeida-Pinto1, Adelino F Leite-Moreira1, Carmen Brás-Silva2

  • 1UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

Current Problems in Cardiology
|April 23, 2022
PubMed
Summary

Congenital heart defects affecting the pulmonary valve require better long-term solutions. Tissue engineering offers promising living valves to overcome limitations of current mechanical and bioprosthetic options.

More Related Videos

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

19.1K
Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.1K

Related Experiment Videos

Last Updated: Sep 26, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.0K
Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

19.1K
Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.1K

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Congenital heart diseases (CHDs) affect 9 per 1000 newborns globally, with 20% impacting the pulmonary valve or right ventricular outflow tract.
  • Improved surgical repair survival necessitates addressing long-term issues in patients with repaired CHDs.
  • Current mechanical and bioprosthetic valves have limitations, including inability to grow and adapt hemodynamically, impacting long-term patient quality of life.

Purpose of the Study:

  • To review the performance of traditional pulmonary valves used in CHD repair.
  • To explore the potential of tissue engineering-based living valves for improved patient management.
  • To address the unmet needs in long-term care for individuals with repaired pulmonary valve defects.

Main Methods:

  • Literature review of traditional pulmonary valve replacements (mechanical and bioprosthetic).
  • Analysis of limitations associated with current prosthetic valve technologies.
  • Exploration of tissue engineering strategies for developing living pulmonary valves.

Main Results:

  • Traditional valves offer improved survival but present suboptimal long-term outcomes due to growth and adaptation limitations.
  • Tissue engineering approaches are being investigated to create living valves that can potentially overcome these limitations.
  • The development of regenerative pulmonary valves is a key area of research for addressing long-term CHD management.

Conclusions:

  • There is a critical need for advanced pulmonary valve solutions beyond current prosthetic options.
  • Tissue engineering holds significant promise for developing living valves that can grow and adapt, improving long-term outcomes for CHD patients.
  • Further research into regenerative pulmonary valves is essential for enhancing the quality of life for individuals with congenital heart conditions.